Interferon alfa-2b biosimilar (PT Kalbe)

干扰素α-2b生物类似药 (PT Kalbe)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2b biosimilar (PT Kalbe)

Drug Alias Nameinterferon alpha-2b follow-on biologic干扰素α-2b生物仿制药 (PT Kalbe)Kalferon

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsMelanomaLymphoma, Non-HodgkinHepatitis C +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesKalbe Farma

China Registration ClassN/A

Active CompaniesKalbe Farma

Inactive CompaniesN/A

Active IndicationsMelanomaLymphoma, Non-HodgkinHepatitis C +[4]

Inactive IndicationsN/A

ATC CodeL03AB05